Literature DB >> 25911103

The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling.

Shuhei Nakane1, Aikichi Iwamoto2, Zene Matsuda3.   

Abstract

The mature human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) comprises the non-covalently associated gp120 and gp41 subunits generated from the gp160 precursor. Recent structural analyses have provided quaternary structural models for gp120/gp41 trimers, including the variable loops (V1-V5) of gp120. In these models, the V3 loop is located under V1/V2 at the apical center of the Env trimer, and the V4 and V5 loops project outward from the trimeric protomers. In addition, the V4 and V5 loops are predicted to have less movement upon receptor binding during membrane fusion events. We performed insertional mutagenesis using a GFP variant, GFPOPT, placed into the variable loops of HXB2 gp120. This allowed us to evaluate the current structural models and to simultaneously generate a GFP-tagged HIV-1 Env, which was useful for image analyses. All GFP-inserted mutants showed similar levels of whole-cell expression, although certain mutants, particularly V3 mutants, showed lower levels of cell surface expression. Functional evaluation of their fusogenicities in cell-cell and virus-like particle-cell fusion assays revealed that V3 was the most sensitive to the insertion and that the V1/V2 loops were less sensitive than V3. The V4 and V5 loops were the most tolerant to insertion, and certain tag proteins other than GFPOPT could also be inserted without functional consequences. Our results support the current structural models and provide a GFPOPT-tagged Env construct for imaging studies.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  envelope glycoprotein; human immunodeficiency virus (HIV); imaging; membrane fusion; mutagenesis; virus entry

Mesh:

Substances:

Year:  2015        PMID: 25911103      PMCID: PMC4463467          DOI: 10.1074/jbc.M114.628610

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein.

Authors:  Nathan C Shaner; Robert E Campbell; Paul A Steinbach; Ben N G Giepmans; Amy E Palmer; Roger Y Tsien
Journal:  Nat Biotechnol       Date:  2004-11-21       Impact factor: 54.908

2.  The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.

Authors:  Levon G Abrahamyan; Samvel R Mkrtchyan; James Binley; Min Lu; Grigory B Melikyan; Fredric S Cohen
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.

Authors:  Dmitry Lyumkis; Jean-Philippe Julien; Natalia de Val; Albert Cupo; Clinton S Potter; Per-Johan Klasse; Dennis R Burton; Rogier W Sanders; John P Moore; Bridget Carragher; Ian A Wilson; Andrew B Ward
Journal:  Science       Date:  2013-10-31       Impact factor: 47.728

4.  Specific covalent labeling of recombinant protein molecules inside live cells.

Authors:  B A Griffin; S R Adams; R Y Tsien
Journal:  Science       Date:  1998-07-10       Impact factor: 47.728

5.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

6.  T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.

Authors:  Y Niwa; M Yano; S Futaki; Y Okumura; H Kido
Journal:  Eur J Biochem       Date:  1996-04-01

7.  Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases.

Authors:  F Vollenweider; S Benjannet; E Decroly; D Savaria; C Lazure; G Thomas; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

Review 8.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

9.  A high precision survey of the molecular dynamics of mammalian clathrin-mediated endocytosis.

Authors:  Marcus J Taylor; David Perrais; Christien J Merrifield
Journal:  PLoS Biol       Date:  2011-03-22       Impact factor: 8.029

10.  Co-expression of foreign proteins tethered to HIV-1 envelope glycoprotein on the cell surface by introducing an intervening second membrane-spanning domain.

Authors:  Hongyun Wang; Xiao Li; Shuhei Nakane; Shujun Liu; Hirohito Ishikawa; Aikichi Iwamoto; Zene Matsuda
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more
  13 in total

Review 1.  Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection.

Authors:  Mario V Beccari; Bryan T Mogle; Eric F Sidman; Keri A Mastro; Elizabeth Asiago-Reddy; Wesley D Kufel
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies.

Authors:  Ujjwal Rathore; Mansi Purwar; Venkada Subramanian Vignesh; Raksha Das; Aditya Arun Kumar; Sanchari Bhattacharyya; Heather Arendt; Joanne DeStefano; Aaron Wilson; Christopher Parks; Celia C La Branche; David C Montefiori; Raghavan Varadarajan
Journal:  J Biol Chem       Date:  2018-08-09       Impact factor: 5.157

3.  Cell-cell and virus-cell fusion assay-based analyses of alanine insertion mutants in the distal α9 portion of the JRFL gp41 subunit from HIV-1.

Authors:  Mizuki Yamamoto; Qingling Du; Jiping Song; Hongyun Wang; Aya Watanabe; Yuetsu Tanaka; Yasushi Kawaguchi; Jun-Ichiro Inoue; Zene Matsuda
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

4.  Click labeling of unnatural sugars metabolically incorporated into viral envelope glycoproteins enables visualization of single particle fusion.

Authors:  Yoon Hyeun Oum; Tanay M Desai; Mariana Marin; Gregory B Melikyan
Journal:  J Virol Methods       Date:  2016-03-29       Impact factor: 2.014

5.  Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer.

Authors:  Kwinten Sliepen; Thijs van Montfort; Gabriel Ozorowski; Laura K Pritchard; Max Crispin; Andrew B Ward; Rogier W Sanders
Journal:  Biomolecules       Date:  2015-10-23

Review 6.  Super-resolution fluorescence microscopy studies of human immunodeficiency virus.

Authors:  Jakub Chojnacki; Christian Eggeling
Journal:  Retrovirology       Date:  2018-06-08       Impact factor: 4.602

Review 7.  On the stability of sequences inserted into viral genomes.

Authors:  Anouk Willemsen; Mark P Zwart
Journal:  Virus Evol       Date:  2019-11-14

Review 8.  Revisiting Membrane Microdomains and Phase Separation: A Viral Perspective.

Authors:  Prabuddha Sengupta; Jennifer Lippincott-Schwartz
Journal:  Viruses       Date:  2020-07-10       Impact factor: 5.048

9.  Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection.

Authors:  Dehua Liu; Hongyun Wang; Mizuki Yamamoto; Jiping Song; Rui Zhang; Qingling Du; Yasushi Kawaguchi; Jun-Ichiro Inoue; Zene Matsuda
Journal:  Retrovirology       Date:  2018-04-02       Impact factor: 4.602

Review 10.  Fluorescence Microscopy of the HIV-1 Envelope.

Authors:  Pablo Carravilla; José L Nieva; Christian Eggeling
Journal:  Viruses       Date:  2020-03-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.